Activation of indices of cell-mediated immunity in bipolar mania

Biological Psychiatry

Volumn 45, Issue 8, 1999, Pages 989-994

  Tsai, Shang Ying ^a   Chen, Kun Po ^b   Yang, Yi Yuan ^a   Chen, Chiao Chicy ^a,b   Lee, Ju Chin ^a   Singh, Vijendra K ^c   Leu, Sy Jye C ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI CITY PSYCHIATRIC CENTER   (Taiwan)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Bipolar disorder; Cell mediated immunity; Mania; Mitogen induced lymphocyte proliferation; Soluble interleukin 2 receptor; Soluble interleukin 6 receptor

Indexed keywords

INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6 RECEPTOR; PHYTOHEMAGGLUTININ;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MALE; MANIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

EID: 0033560674     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00159-0     Document Type: Article

References (34)

1. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, rev. 1987;American Psychiatric Press, Washington, DC.
2. Barsi J., Rihmer Z., Lajos J., Czecze Ë., Varga M., Aratö M. Reduced cellular immune function in major depression and mania. Psychiatry Res. 29:1989;235-237.
3. Caruso C., Candore G., Cigna D., Colucci A.T., Modica M.A. Biological significance of soluble IL-2 receptor. Med Inflamm. 2:1993;3-21.
4. Darko D.F., Gillin C., Risch S.C., Bulloch K., Golshan S., Tasevska Z., et al. Mitogen-stimulated lymphocyte proliferation and pituitary hormones in major depression. Biol Psychiatry. 26:1989;145-155.
5. Darko D.F., Wilson N.W., Gillin J.C., Golshan S. A critical appraisal of mitogen-induced lymphocyte proliferation in depressed patients. Am J Psychiatry. 148:1991;337-344.
6. Haggerty J.J., Evans D.L., Golden R.N., Pedersen C.A., Simon J.S., Nemeroff C.B. The presence of antithyroid antibodies in patients with affective and non-affective psychiatric disorders. Biol Psychiatry. 27:1990;51-60.
7. Hickie I., Hickie C., Lloyd A., Silove D., Wakefield D. Impaired in vivo immune responses in patients with melancholia. Br J Psychiatry. 162:1993;651-657.
8. Hornberg M., Arolt V., Wilke I., Kruse A., Kirchner H. Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia. Schizophr Res. 15:1995;237-242.
9. Jones J.M., Yeralan O., Hines G., Maher M., Roberts D.W., Benson R.W. Effects of lithium and rubidium on immune responses of rats. Toxicol Lett. 52:1990;163-168.
10. Kim C.E., Kang D.Y., Ha K.S., Jeong S.H., Kim Y.S. Haloperidol does not affect the level of serum-soluble interleukin-2 receptor in drug-free male schizophrenics. Biol Psychiatry. 38:1995;843-845.
11. Kronfol Z., House J.D. Immune function in mania. Biol Psychiatry. 24:1988;341-343.
12. Maes M., Bosmans E., Suy E., Vandervorst C., DeJonckheere C., Raus J. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1β and soluble interleukin-2 receptor production. Acta Psychiatr Scand. 84:1991;379-386.
13. Maes M., Stevens W., DeClerck L., Bridts C., Peeters D., Schotte C., et al. Immune disorders in depression Higher T helper/T suppressor-cytotoxic cell ratio . Acta Psychiatr Scand. 86:1992;423-431.
14. Maes M., Meltzer H.Y., Bosmans E. Immune-inflammatory markers in schizophrenia Comparison to normal controls and effects of clozapine . Acta Psychiatr Scand. 89:1994;346-351.
15. Maes M., Bosmans E., Calabrese J., Smith R., Meltzer H.Y. Interleukin-2 and interleukin-6 in schizophrenia and mania Effects of neuroleptics and mood stabilizers . J Psychiatr Res. 29:1995;141-152.
16. Maes M., Meltzer H.Y., Bosmans E., Bergmans R., Vandoolaeghe E., Ranjan R., et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord. 34:1995;301-309.
17. Maes M., Bosmans E., Ranjan R., Vandoolaeghe E., Meltzer H.Y., De Ley M., et al. Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia Effects of antipsychotic drugs . Schizophr Res. 21:1996;39-50.
18. Maes M., Delanghe J., Ranjan R., Meltzer H.Y., Desnyder R., Cooremans W., et al. Acute phase proteins in schizophrenia, mania and major depression Modulation by psychotropic drugs . Psychiatry Res. 66:1997;1-11.
19. Müller N., Ackenheil M., Hofschuster E. Altered T cell number and reduced suppressor cell activity in patients with affective psychosis. Int CNS Neuroendocr Immune Syst. 31:1989;385-394.
20. Pollmächer T., Hinze-Selch D., Fenzel T., Kraus T., Schuld A., Mullington J. Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol. Am J Psychiatry. 154:1997;1763-1765.
21. Rapaport M.H. Immune parameters in euthymic bipolar patients and normal volunteers. J Affect Disord. 32:1994;149-156.
22. Rapaport M.H., Lohr J.B. Serum soluble interleukin-2 receptors in neuroleptic native schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia. Acta Psychiatr Scand. 90:1994;311-315.
23. Rapaport M.H., McAllister C.G., Pickar D., Nelson D.L., Paul S.M. Elevated levels of soluble interleukin-2 receptors in schizophrenia. Arch Gen Psychiatry. 46:1989;291-292.
24. Rapaport M.H., Torrey E.F., McAllister C.G., Nelson D.L., Pickar D., Paul S.M. Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins. Eur Arch Psychiatry Clin Neurosci. 242:1993;7-10.
25. Rapaport M.H., McAllister C.G., Kim Y.S., Han J.H., Pickar D., Nelson D.L., et al. Increased serum soluble interleukin-2 receptors in Caucasian and Korean schizophrenic patients. Biol Psychiatry. 35:1994;767-771.
26. Rapaport M.H., Schmidt M.E., Risinger R., Manji H. The effects of prolonged lithium exposure on the immune system of normal control subjects Serial serum soluble interleukin-2 receptor and antithyroid antibody measurements . Biol Psychiatry. 35:1994;761-766.
27. Schleifer S.J., Keller S.E., Bond R.N., Cohen J., Stein M. Major depressive disorder and immunity Role of age, sex, severity, and hospitalization . Arch Gen Psychiatry. 46:1989;81-87.
28. Schleifer S.J., Keller S.E., Bartlett J.A., Eckholdt H.M., Delaney B.R. Immunity in young adults with major depressive disorder. Am J Psychiatry. 153:1996;477-482.
29. Sluzewska A., Rybakowski J., Bosmans E., Sobieska M., Berghmians R., Maes M., et al. Indicators of immune activation in major depression. Psychiatry Res. 64:1996;161-167.
30. Smith R.S. A comprehensive marcophage-T-lymphocyte theory of schizophrenia. Med Hypotheses. 39:1992;248-257.
31. Tsai S.Y., Chen C.C., Yeh E.K. Alcohol problems and long-term psychosocial outcome in Chinese patients with bipolar disorder. J Affect Disord. 46:1997;143-150.
32. Tsai S.Y., Lee J.C., Chen C.C., Chen J., Chao W.S., Chen K.P. Co-existing physical illnesses in help-seeking patients of bipolar disorder. Taiwanese Psychiatry. 11:1997;249-261.
33. Wilson R, Fraser WD, McKillop JH, Smith J, O'Reilly D St. J., Thomson JA (1989): The "in vitro" effects of lithium on the immune system. Autoimmunity 4:109-114.
34. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania Reliability, validity and sensitivity . Br J Psychiatry. 153:1978;429-435.